Daily Brief Archive: July 16, 2026 — U.S. & Hong Kong Stock Analysis

Free preview

U.S. Markets

  • June CPI fell 0.4% m/m — the biggest drop since April 2020 — with the annual rate at 3.5% vs 3.8% expected
  • Warsh's debut testimony leaned hawkish — 'not mission accomplished' — a hot speech cooling a cold print
  • IBM crashed 25.2%, its worst day in 115 years, on a Q2 warning: customer budgets shifted to AI hardware
  • Memory's second leg down: Micron -12% over two days (China competition + profit-taking), SanDisk -8%, SK Hynix ADR -9%
  • PayPal +17% on the Stripe/Advent/Block consortium's $53B, $60.50-a-share bid
  • Bank earnings bloomed: JPMorgan smashed, Morgan Stanley profit +58%, BlackRock/BNY and the Canadian trio at records

Hong Kong

  • HK screeners nearly empty this morning — volume hasn't woken up; only Seres made a channel
  • Alibaba +2.5% at HK$116.20, pressing the 50-day; the AI re-rating is +19.9% on the week
  • Asymchem printed a record HK$138.70 before settling at 133.70; the CXO duo's high-for-high resonance continues
  • Seres bounced 5.2% this morning — a dead cat after guiding to a RMB 1.5–1.8B interim loss, 67.5% below its IPO price
  • Tencent at HK$478, +3.6% on the week, as the tech repair broadens to second-tier names

Today's Watchlist

  • Earnings minefield week: TSM/ASML ripples spreading; 7/22 brings TSLA and the already-warned IBM
  • PayPal's board meets 7/20 on the bid; payments peers (Block, ACI Worldwide) re-rate in sympathy
  • Position tripwires: MU $880, TSLA $390, AMD $518, BEAM $30.50, CELH $29.60
  • IBM post-mortem: the stop was gapped straight through — halving size into event windows is now written into the rulebook
  • Geopolitics cooling watch: energy fell off the hot list and Valero gave back — the Hormuz premium is being digested

Deep Dives (3 names)

Long
Score7/10Breakout confirmed Cleared the HK$130 prior high; new 52-wk high HK$138.70Since entry 7/14 at HK$127.60 → +4.8%Week / month +20.1% / +42.2%RSI(14) 69.9Bank target avg HK$136.0

Technicals — Flat at HK$133.70 this morning after yesterday's push to a record HK$138.70. The MA stack is fully bullish (20-day at HK$112.69) and the cleared HK$130 now flips to support; RSI at 69.9 is borderline, with volume confirmation pending this afternoon's session.

Fundamentals — The CXO duo keeps resonating — WuXi Bio (2269, held) printed another high the same day. The warming peptide/small-molecule order cycle and interim-report visibility remain the spine, and the RMB-1 H-share incentive still aligns management.

News — No fresh filings; the HK$136 average bank target has been caught by the price — the CXO sector is now testing the earnings-drive-targets-higher loop, with interims as the next catalyst.

Short-term · 1–3 weeks
Long Lean bullish

With the breakout confirmed, trailing the stop is the entire management plan: no adds in the RSI-70 zone, HK$150 as the measured-move target, and a break of HK$122 would brand it a failed breakout — take the loss and go.

Entry Hold with the stop raised from HK$115 to HK$122 (an ATR under the cleared 130); a holding retest of HK$128–131 is healthy confirmationStop HK$122Target HK$150
Long-term · months+
Accumulate

A warming CXO cycle with peptide (GLP-1 spillover) order torque and utilization-driven operating leverage; incentives align management.

  • Geopolitical (Biosecure-style) risk resurfacing
  • Order-cycle volatility
  • Near-term pullback risk from overbought levels
Signal BacktestCumulative +4.78%price itself +4.78%profitable since 07-16
  • 07-14LongHK$127.6 → open → HK$133.7+4.78%
Community Voices
  • 雪球 · Post-record comments split between profit screenshots and bubble calls — in breakouts, the screenshot crowd always exits before the top-callers; it's traditionOriginal ↗
Institutional Views
  • 华尔街共识 · 8 analysts average HK$135.96 — 1.7% above spot; the breakout has caught the targets, and the pressure to raise now sits with the analysts
Long
Score8/10Week +19.9%Key level Pressing the 50-day at exactly HK$116.20Position P&L ~+16% since inclusionRSI(14) 62.7Consensus target HK$185 (+59.3%)

Technicals — Up 2.5% this morning to HK$116.20, dead level with the 50-day. RSI 62.7 is healthy with the 20-day far below at HK$102; the overhead gap and HK$120 round number form the second test, with volume telling this afternoon.

Fundamentals — The ~45% cloud-growth preview and the Qwen 4.0 productivity-suite story keep fermenting; the banks' 'reprice AI assets' thesis remains the fuel layer, with the late-August report as the next checkpoint.

News — No fresh news; against an empty HK screener morning it led the book with +2.5%, and the +19.9% week is the portfolio's strongest momentum.

Short-term · 1–3 weeks
Long Bullish

The strongest momentum in the book earns the tightest trailing stop; three failed attempts at the 50-day would mean fading thrust, at which point protecting gains outranks chasing targets.

Entry Hold with the stop raised from HK$105 to HK$108; a volume move through the 50-day and HK$120, then a holding retest, is the add-watchStop HK$108Target HK$130
Long-term · months+
Accumulate

Early innings of the cloud+AI re-rating at a discount to US peers, with commerce cash flow funding the capex cycle.

  • LLM monetization underdelivering
  • Technical rejection at the 50-day/HK$120 double gate
  • Weak consumption recovery
Signal BacktestCumulative +16.17%price itself +23.49%0/1 closed trades wonprofitable since 07-09
  • 07-02LongHK$94.5 → closed HK$94.107-04-0.42%
  • 07-08LongHK$99.6 → open → HK$116.2+16.67%
Community Voices
  • 雪球 · 'Does it clear the 50-day' is the pinned debate — chartists and fundamentalists rarely stare at the same line, and that shared gaze amplifies whichever break comesOriginal ↗
Institutional Views
  • 华尔街共识 · 34 analysts average HK$185 — 59.3% above spot; 1.16 rating
Neutral
Score5/10Interim guidance RMB 1.5–1.8B loss (vs a 2.94B profit a year ago)AITO Q2 A 1.9–2.15B quarterly lossVs IPO price -67.5%RSI(14) 29.4This morning +5.2% oversold snap

Technicals — Up 5.2% this morning at HK$43.56, still under the 20-day (HK$48) and 50-day (HK$59.62). This is the first snap after 7/13's 13.6% gap-down to a record low HK$40.30; RSI 29.4. Half a year post-listing there's no 200-day — no valuation anchor, only positioning.

Fundamentals — Why it flipped to losses matters more than the size: AITO volume declines, the price war and channel subsidies produced a Q2 loss of RMB 1.9–2.15B that swallowed everything. The Huawei tie-up is traffic and cost at once — the 'Huawei content' just showed up on the P&L as a negative number for the first time.

News — The interim loss warning landed after hours on 7/12 and both listings slid 7/13 (H-shares -13.6% to a record low). Coverage tracks it 67.5% below the IPO price; this morning it was the only name the HK oversold screener produced.

Short-term · 1–3 weeks
Neutral Sidelines

The first loss warning is rarely the last. Oversold-snap traders earn intraday money while carrying fundamental risk — the trade-off simply doesn't clear.

Entry Pass: three days after a loss warning, secondary shoes (impairments, volume data) haven't dropped; HK$40.30 — the record low — is the only level worth watching, and losing it enters no-man's landStop —Target —
Long-term · months+
Avoid

Until AITO volumes and a profit path re-clarify, the H-shares have no valuation anchor; Huawei-concept option value can't cover the certainty of ongoing losses.

  • AITO volumes falling further
  • The price war extending the loss cycle
  • Asymmetric risk from Huawei partnership-term changes
Community Voices
  • 雪球 · The 'can AITO turn it around' thread runs hundreds of floors deep — bottom debates are always the loudest, and real bottoms arrive when nobody's arguingOriginal ↗
Institutional Views
  • 华尔街共识 · 14 analysts average HK$114.43 — 162% above spot; an IPO-era relic with zero anchoring value today
  • 腾讯新闻 · Profits flipped to losses with the stock down 68% — 'buckling' is the coverage keywordSource ↗
  • 新浪财经 · Both listings slid as the interim loss confirms the fundamental inflectionSource ↗

Rapid Scan (9 names)

TickerCloseChangeScoreDirectionOne-line take
700 logo700HKHK$478+0.84%7LongUp 0.8% this morning at HK$478.00, the +3.6% week putting 6% between price and stop — last week's line-hugging agony bought this week's calm; stop raised to HK$460, holding
1211 logo1211HKHK$86.55-0.46%7LongDown 0.5% this morning at HK$86.55 — Seres' loss warning only flatters BYD's export-and-scale chassis; stop HK$78, holding
1810 logo1810HKHK$26.12+1.01%7LongUp 1.0% this morning at HK$26.12, momentum extending after an +11.1% week; holding
3690 logo3690HKHK$84.45+1.26%7LongUp 1.3% this morning at HK$84.45, +8.5% on the week as the consolidation resolves upward; stop raised to HK$76, holding
1801 logo1801HKHK$97-0.05%7LongFlat this morning at HK$97.00, one step from the round number — RSI 72 runs hot but the innovative-drug theme is +24.4% on the month; stop raised to HK$88, holding
2269 logo2269HKHK$39.7+0.40%7LongUp 0.4% this morning at another high of HK$39.70 — the CXO pas de deux with Asymchem plays on; stop HK$35, holding
2899 logo2899HKHK$30.24+0.13%6LongUp 0.1% this morning at HK$30.24, consolidating high in the gold-copper repair leg; holding
2259 logo2259HKHK$101.7+2.52%6LongUp 2.5% this morning back above the HK$100 mark at HK$101.70, escape velocity holding; stop stays HK$95
5 logo5HKHK$156+0.45%7LongUp 0.5% this morning at a 52-week high of HK$156.00 — the HK echo of the US bank feast; holding
Stock Brief 2026-07-16: Daily U.S. & HK Market Analysis Archive · Quant Brief